Company intelligence / Profile preview

Parachute

Ownership: Private
Employees: ~205
Development stage: Commercial

Overview

Parachute is an independent plasma collection company that leverages technology to make the donation process more convenient and efficient. They focus on improving donor experience through a user-friendly app and modern centers. Their efforts help address the ongoing shortage of plasma needed for life-saving medicines used in chronic illnesses[1][2][4]. In May 2025, they adopted Terumo BCT’s Rika Plasma Donation System to further improve efficiency and comfort for donors[3].

Modalities: Plasma donation (for plasma-derived therapies)
Industry: Non-Academic Healthcare

Partnerships

Terumo Blood and Cell Technologies (Terumo BCT) – partnership for adoption of Rika Plasma Donation System[3]

Beyond the preview

Go deeper on Parachute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parachute.

Explore the full profile